• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prescribing patterns of antilipemic drugs and prevalence of hypercholesterolemia in the Nova Scotia population more than 65 years old.新斯科舍省65岁以上人群中抗血脂药物的处方模式及高胆固醇血症的患病率。
Ann Pharmacother. 1995 Jun;29(6):576-81. doi: 10.1177/106002809502900604.
2
Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.1990年至2001年指南对加拿大两个省份(艾伯塔省和新斯科舍省)血脂异常管理中医疗保健使用的影响。
Can J Cardiol. 2004 Jun;20(8):767-72.
3
Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.他汀类抗血脂药物使用情况的量化:加拿大新斯科舍省与澳大利亚昆士兰州的比较与对比。
Clin Ther. 2005 Apr;27(4):497-508. doi: 10.1016/j.clinthera.2005.04.009.
4
Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).比较澳大利亚和新斯科舍省(加拿大)非甾体抗炎药和环氧化酶-2(COX-2)抑制剂的使用情况。
Br J Clin Pharmacol. 2009 Jul;68(1):106-15. doi: 10.1111/j.1365-2125.2009.03410.x.
5
Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies.加拿大曼尼托巴省、新斯科舍省和萨斯喀彻温省老年人抗感染药物使用情况比较:与药物保险报销政策的关系
Am J Geriatr Pharmacother. 2004 Mar;2(1):24-35. doi: 10.1016/s1543-5946(04)90004-9.
6
A comparison of benzodiazepine and related drug use in Nova Scotia and Australia.新斯科舍省与澳大利亚苯二氮䓬类药物及相关药物使用情况比较。
Can J Psychiatry. 2008 Aug;53(8):545-52. doi: 10.1177/070674370805300809.
7
Management of high blood cholesterol levels in Nova Scotian adults: comparison with the NCEP II and European clinical practice guidelines.
Am J Manag Care. 2000 Sep;6(9):1017-28.
8
Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.基于人群的心房颤动抗栓治疗管理评估
Can J Cardiol. 2005 Mar;21(3):257-66.
9
A comparison of antidepressant use in Nova Scotia, Canada and Australia.加拿大新斯科舍省与澳大利亚抗抑郁药使用情况的比较。
Pharmacoepidemiol Drug Saf. 2008 Jul;17(7):697-706. doi: 10.1002/pds.1541.
10
Suboptimal use of antidepressants in the elderly: a population-based study in Nova Scotia.老年人对抗抑郁药的使用不充分:一项基于新斯科舍省人群的研究。
Clin Ther. 1999 Nov;21(11):1937-50. doi: 10.1016/S0149-2918(00)86741-7.

引用本文的文献

1
The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.美国食品药品监督管理局(FDA)和加拿大卫生部发布的与大剂量辛伐他汀安全性相关警告的影响
Drugs Real World Outcomes. 2017 Dec;4(4):215-223. doi: 10.1007/s40801-017-0116-7.

新斯科舍省65岁以上人群中抗血脂药物的处方模式及高胆固醇血症的患病率。

Prescribing patterns of antilipemic drugs and prevalence of hypercholesterolemia in the Nova Scotia population more than 65 years old.

作者信息

Sketris I S, Kephart G C, Hicks V A, Hubbard E J, Brown M G, Chandler R F, MacLean D R

机构信息

College of Pharmacy, Dalhousie University, and Clinical Consultant, Department of Pharmaceutical Services, Victoria General Hospital, Halifax, Nova Scotia.

出版信息

Ann Pharmacother. 1995 Jun;29(6):576-81. doi: 10.1177/106002809502900604.

DOI:10.1177/106002809502900604
PMID:7663028
Abstract

OBJECTIVE

To examine the prevalence of antilipemic drug use, demographic characteristics of patients using these drugs, and the prevalence of hypercholesterolemia in the Nova Scotia population over 65 years of age.

DESIGN

Information was collected on the prescribing of antilipemic drugs using Nova Scotia Medical Services Insurance Pharmacare program data from October 1991 through March 1992. Pharmacare data were compared with prevalence data on increased low-density lipoprotein (LDL) cholesterol concentrations obtained from the Nova Scotia Heart Health Survey (NSHHS).

SETTING

Pharmacare is a centrally administered drug insurance system maintained in computerized claims files since 1974. It provides prescription drugs to all residents of Nova Scotia who are at least 65 years old and who are insured under the provincial Medicare program.

PARTICIPANTS

In the 1991-1992 fiscal year, 47,000 men and 65,700 women were eligible for Pharmacare. The NSHHS was administered to a probability sample of 2,108 individuals, representative of the 1986 population aged 18-74 years.

MAIN OUTCOME MEASURES

Prescriptions for antilipemic agents.

RESULTS

The NSHHS data indicated that 3.7% of women and 2.3% of men at least 65 years old and 4.8% of women and 2.8% of men 65-74 years old received a prescription for antilipemic drugs.

摘要

目的

研究新斯科舍省65岁以上人群中抗血脂药物的使用情况、使用这些药物的患者的人口统计学特征以及高胆固醇血症的患病率。

设计

利用1991年10月至1992年3月新斯科舍省医疗服务保险药物护理计划的数据收集抗血脂药物的处方信息。将药物护理数据与从新斯科舍省心脏健康调查(NSHHS)获得的低密度脂蛋白(LDL)胆固醇浓度升高的患病率数据进行比较。

背景

药物护理是一个自1974年起以计算机化理赔档案形式维持的中央管理的药物保险系统。它为所有年满65岁且参加省级医疗保险计划的新斯科舍省居民提供处方药。

参与者

在1991 - 1992财政年度,47000名男性和65700名女性符合药物护理资格。NSHHS对2108名个体的概率样本进行了调查,这些个体代表了1986年18 - 74岁的人群。

主要观察指标

抗血脂药物的处方。

结果

NSHHS数据表明,65岁及以上的女性中有3.7%、男性中有2.3%,65 - 74岁的女性中有4.8%、男性中有2.8%接受了抗血脂药物处方。